Cronos Group Inc. (NASDAQ:CRON - Get Free Report) was the target of some unusual options trading on Tuesday. Stock investors purchased 2,690 call options on the stock. This is an increase of approximately 147% compared to the average daily volume of 1,091 call options.
Cronos Group Price Performance
CRON stock traded up $0.12 during mid-day trading on Tuesday, reaching $3.52. 803,696 shares of the company's stock were exchanged, compared to its average volume of 1,336,843. Cronos Group has a 12-month low of $2.28 and a 12-month high of $3.54. The stock's 50 day moving average is $2.88 and its 200 day moving average is $2.72. The company has a market cap of $1.31 billion, a price-to-earnings ratio of 17.63 and a beta of 0.90.
Cronos Group (NASDAQ:CRON - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.08. Cronos Group had a return on equity of 4.85% and a net margin of 39.08%.The business had revenue of $53.01 million during the quarter, compared to analysts' expectations of $44.20 million. On average, research analysts forecast that Cronos Group will post 0.11 earnings per share for the current fiscal year.
Institutional Trading of Cronos Group
Several institutional investors have recently modified their holdings of the stock. Pillsbury Lake Capital LLC acquired a new stake in Cronos Group in the 4th quarter worth about $4,837,000. Cibc World Market Inc. acquired a new position in shares of Cronos Group during the second quarter valued at approximately $3,820,000. Arrowstreet Capital Limited Partnership lifted its position in shares of Cronos Group by 1,135.6% in the third quarter. Arrowstreet Capital Limited Partnership now owns 1,108,131 shares of the company's stock valued at $3,075,000 after acquiring an additional 1,018,448 shares in the last quarter. MMCAP International Inc. SPC lifted its position in shares of Cronos Group by 56.1% in the fourth quarter. MMCAP International Inc. SPC now owns 2,761,059 shares of the company's stock valued at $7,262,000 after acquiring an additional 991,977 shares in the last quarter. Finally, Oasis Management Co Ltd. purchased a new position in shares of Cronos Group in the fourth quarter valued at approximately $2,409,000. Institutional investors and hedge funds own 8.71% of the company's stock.
Analyst Ratings Changes
Several research firms recently issued reports on CRON. TD Securities reiterated a "buy" rating on shares of Cronos Group in a research note on Tuesday, May 12th. Wall Street Zen cut shares of Cronos Group from a "buy" rating to a "hold" rating in a report on Saturday, August 15th. Finally, Weiss Ratings upgraded shares of Cronos Group from a "sell (d+)" rating to a "hold (c+)" rating in a research report on Wednesday, August 12th. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $2.30.
Check Out Our Latest Stock Analysis on Cronos Group
About Cronos Group
(
Get Free Report)
Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. Headquartered in Toronto, Ontario, the company manages operations that span the full cannabis value chain, including breeding, greenhouse cultivation, extraction, product formulation and packaging. Cronos Group's business model emphasizes innovation in product development and scalability in manufacturing to meet evolving regulatory and consumer demands.
The company's branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
